Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

pembrolizumab 161 Nivolumab 133 Ipilimumab 78 Cyclophosphamide 47 Specimen Handling 44 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 29 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 22 fludarabine phosphate 21 dabrafenib 20 atezolizumab 20 Radiotherapy 20 Opdualag 19 aldesleukin 18 Radiosurgery 18 CTLA-4 Antigen 18 encorafenib 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lifileucel 11 lenvatinib 11 Bevacizumab 11 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Laser Speckle Contrast Imaging × Dermatologic × 1 year × Clear all

NCT01455363 2025-11-24

HPOB

Institut Curie

Phase NA Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡